All Type of News
Concerns growing over domestic market entry of leading generic companies
Korean pharmaceutical firms are jittery over possible entry of leading foreign companies, such as Cipla Limited and Teva.
Cipla Limited is looking to seek Korean partners to market their hundreds of generic medicat...
Anyang City R&D center to attract pharmaceutical firms
To transform Anyang of Kyunggi Province into a research and development (R&D) hub, the city government plans to set up a R&D center for development of new drugs at a newly created site.
The center will accommodate ...
Government to get tough on duplicate prescriptions
Patient will not be able to receive the duplicate prescription of same medicines over the same disease from three hospitals from August, according to the Ministry of Health, Welfare and Family Affairs.
The health ...
Hanmi in tie-up with Samsung Electronics
Hanmi Pharm said on July 20 that it signed a Memorandum of Understanding (MOU) with Samsung Electronics, the world's No. 2 maker of chips and handsets, to exclusively market a table-type ionizer purifier “Virus Doctor...
169 clinical trials approved in first half
The Korea Food and Drug Administration said it approved a total of 169 clinical trials in the first half of this year.
The number of clinical trials conducted by domestic pharmaceutical firms, such as Boryung Pharm...
Drugs can spur photosensitivity reactions
In summer, drug-induced photosensitivity reactions (sensitivity to UVA rays of the sun or tanning devices) may result in an exaggerated sunburn or, more rarely, an allergic reaction with itching and a blister-...
Dongwha to change name to Dongwha Pharm
Dongwha Pharm Ind. changed its name to Dongwha Pharm, the company said in its recent regulatory filing.
The company also said its par value per share will be split from 5,000 won to 1,000 won and as a result, the c...
Chong Kun Dang sees slow Penzal drink sales
Penzal tablet is a very popular pain reliever in the domestic market, but the sales of its drink form is far below the firm's expectation since its launching at the end of last year.
Such a performance is disappoin...
Binex stocks shoot up in July
The stocks of Binex Co. a local biopharmaceutical company, surged as much as 14.7 percent to 18,250 won on July 16 amid optimism that its business will improve as the government’s plan to inject 155 billion won into 2...
55 pharmaceutical manufacturers given summary indictment over blacklisted drugs
The Seoul Central Prosecutors Office has recently lodged a summary indictment against 55 pharmaceutical manufacturers and 4 baby powder makers for using cheap Chinese talc containing asbestos.
The prosecutors said ...
